TVNewser Show TVNewser AgencySpy TVSpy LostRemote FishbowlNY FishbowlDC SocialTimes AllFacebook 10,000 Words GalleyCat UnBeige MediaJobsDaily

Posts Tagged ‘FDA’

PR Nightmare: Teen Deaths Tied to Monster Energy Drink

We never thought an “energy drink” could have a poorer public reception than Four Loko, but Monster appears to have landed in an even deeper ditch—and its products don’t even contain alcohol!

A certain big-deal organization known as the FDA just released a report asserting that as many as five people died over the past three years after drinking Monster. While the report draws no direct, indisputable link between Monster and the tragedies in question, we can all agree that this sort of story is every company’s worst PR nightmare.

The victims, all of whom were teenagers, had a couple of crucial factors in common: each of them drank one or more 24-ounce cans of Monster less than 24 hours before dying of heart failure. The FDA also received multiple reports of consumers experiencing problems like “abdominal pain, vomiting, tremors and abnormal heart rate” after drinking Monster.

Does the drink really pose a risk to the general public? While every can contains 240 milligrams of caffeine, company representatives note that the average 16-ounce cup of coffee contains even more of the potentially damaging stimulant. That point may be irrelevant, though. The case got a lot bigger last week when one of the victims’ mothers responded to her daughter’s death by filing a lawsuit against the publicly traded company; its stock prices (NYSE: MNST) fell accordingly.

Read more

Spin the Agencies of Record

Hyundai’s dedicated shop, Innocean, has secured its first non-auto client in the U.S. FootJoy, the maker of performance-wear golf products, hired the company to launch a repositioning campaign that includes social media, TV and digital responsibilities.

Rob Kelley, FootJoy’s director of brand marketing, explained that Innocean “demonstrated a deep understanding of the game, our business and the ability to capture the consumer’s attention through fully integrated campaigns across all channels, just a few of the factors that led to their selection in this review process.”

The FDA has selected six agencies to work on its anti-smoking educational campaigns. The agencies, which will support different responsibilities under the new effort, include Interpublic Group‘s Campbell-Ewald, True North Communications, Mullen Communications, WPP’s Grey Global Group, the independent agency Riester and the American Legacy Foundation. Some agencies will allocate work to agency partners. The campaigns are mostly funded by tax-like fees from tobacco companies, which collectively involve a maximum of $390 million awarded over five years. Read more

Pharma Marketers: FDA Taking Too Long Developing Social Media Guidelines

pills12.jpg

The FDA held public hearings just last week to discuss establishing guidelines for pharmaceutical marketers operating in the new world of social media. Already some are complaining that the process is taking too long.

“Does the FDA get it?” If it did, “they wouldn’t be having this meeting now, many, many months after it was already apparent how quickly Web communications is changing,” Mark Senak, author of the blog Eye on FDA and a senior vice-president at Fleishman-Hillard told BusinessWeek.

John Bell, President of the Board of Word of Mouth Marketing Association and Managing Director, Ogilvy Public Relations Worldwide agreed that things will take a while. “We’re spending time today in initial discussions that is as much about how the process should unfold as it is what should be the precise guidelines,” he told PRNewser last week.

Ogilvy’s John Bell: FDA Social Media Guidelines Will “Basically Follow Same Process” As FTC Blogging Guidelines

John_Bell.jpg

John Bell, President of the Board of Word of Mouth Marketing Association and Managing Director, Ogilvy Public Relations Worldwide, was one of the last presenters today at the FDA’s public hearings on “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools.” We caught up with Bell late yesterday to get his take on the proceedings.

Asked about how much of the hearings pertained to advertising and how much pertained to PR, Bell said, “Today’s stated focus is about what guidelines should be developed for social media, which is this netherworld in between paid and earned media. Unfortunately it covers all grounds.”

Part of the problem, Bell said, is that health-care marketers, “can’t jam all the crap you put into a print ad into a tweet.” So, what is end game with all of this? “We’re spending time today in initial discussions that is as much about how the process should unfold as it is what should be the precise guidelines.” PRNewser’s takeaway: this is going to take a while.

Bell and WOMMA were heavily involved in the recently issued FTC guidelines around disclosure in social media. Drafts for those guidelines were posted for comment late last year, he said, and the final draft came out in October. “I think what will happen with the FDA, is basically to kind of follow the same process,” he said.

<< PREVIOUS PAGE